Published in Arch Dermatol on December 01, 1974
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Senear-Usher syndrome (pemphigus erythematosus). Immunofluorescent studies in a patient. Arch Dermatol (1970) 1.45
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09
Bullous pemphigoid in an 11-year-old boy. Arch Dermatol (1970) 1.07
Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07
Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03
Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02
Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00
Hodgkin's disease with specific bullous lesions. Am J Dermatopathol (1980) 0.99
Herpes gestationis. New immunologic findings. Arch Dermatol (1974) 0.99
Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol (1985) 0.99
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
Complement activation in bullous skin diseases. J Invest Dermatol (1975) 0.98
Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material. J Invest Dermatol (1980) 0.96
Complement activation in pemphigus and bullous pemphigoid. J Invest Dermatol (1976) 0.96
C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol (1977) 0.96
Recurrent oral erythema multiforme. Clinical experience with 11 patients. JAMA (1983) 0.96
Vasculitis in chronic urticaria: an immunopathologic study. J Invest Dermatol (1981) 0.95
Antinuclear antibodies: their significance in scleroderma. Mayo Clin Proc (1971) 0.95
Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile. Clin Exp Immunol (1974) 0.94
Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin. J Invest Dermatol (1989) 0.93
Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol (1988) 0.93
Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol (1985) 0.93
Immunofluorescent skin test in systemic lupus erythematosus. Lack of relationship with renal disease. JAMA (1972) 0.92
Direct immunofluorescence in the diagnosis of scleroderma syndromes. Br J Dermatol (1977) 0.91
The genetics of hyperkeratosis lenticularis perstans. Arch Dermatol (1972) 0.91
Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol (1996) 0.90
Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. J Invest Dermatol (1986) 0.89
Proflavine staining of the skin demonstrated by fluorescent microscopy. Arch Dermatol (1973) 0.89
Separation of epidermis from dermis with sodium thiocyanate. J Invest Dermatol (1977) 0.88
Oral acyclovir for the prevention of herpes-associated erythema multiforme. J Am Acad Dermatol (1986) 0.88
"An unusual type of pemphigus combining features of lupus erythematosus" by Senear and Usher, June 1926. Commentary: Pemphigus erythematosus, a unique member of the pemphigus group. Arch Dermatol (1982) 0.88
Vesicular pemphigoid. Arch Dermatol (1976) 0.88
Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin. J Invest Dermatol (1984) 0.87
Cicatricial pemphigoid. Immunofluorescent studies. Arch Dermatol (1974) 0.87
Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol (1978) 0.87
Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies. Proc Soc Exp Biol Med (1976) 0.87
Oesophageal involvement in bullous pemphigoid. A possible cause of gastrointestinal haemorrhage. Br J Dermatol (1978) 0.86
Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes. J Lab Clin Med (1990) 0.86
Immunofluorescent studies of ocular cicatricial pemphigoid. Am J Ophthalmol (1975) 0.86
The complement system in pemphigus, bullous pemphigoid and herpes gestationis. Int J Dermatol (1979) 0.86
Pemphigus-like antibodies in bullous pemphigoid. Arch Dermatol (1977) 0.85
Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus. Br J Dermatol (1975) 0.85
Neonatal pemphigus foliaceus. Arch Dermatol (1995) 0.82
The complement system in bullous pemphigoid. IV. Chemotactic activity in blister fluid. Clin Immunol Immunopathol (1976) 0.82
Immunopathology of cicatricial pemphigoid: studies of complement deposition. J Invest Dermatol (1977) 0.82
Immunofluorescent studies of dermatomyositis. Dermatologica (1972) 0.82
The particulate (speckled-like thread) nuclear staining pattern: species and cellular distribution of Ro/SSA antigen. J Clin Lab Immunol (1987) 0.82
Systemic lupus erythematosus presenting as a bullous eruption in a child. Arch Dermatol (1988) 0.82
Cicatricial pemphigoid. Immunofluorescent studies. Arch Dermatol (1972) 0.81
Neonatal lupus erythematosus. A report of three cases associated with anti-Ro/SSA antibodies. Arch Dermatol (1985) 0.81
An appraisal of routine direct immunofluorescence in vulvar disorders. Acta Derm Venereol (1981) 0.81
Blister fluid in pemphigus. J Invest Dermatol (1969) 0.81
Complement fixation by Brazilian Pemphigus foliaceus autoantibodies. Clin Exp Immunol (1988) 0.81
Bullous pemphigoid: a cause of peripheral blood eosinophilia. J Am Acad Dermatol (1983) 0.80
Bullous scabies. JAMA (1974) 0.80
Ocular cicatricial pemphigoid (immunologic studies). Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol (1977) 0.80
Expression of pemphigus vulgaris antigen in cultured human keratinocytes: effect of inhibitors, tunicamycin, and lectins. J Invest Dermatol (1988) 0.80
Pemphigus involving the eyes. Arch Dermatol (1975) 0.80
Clq binding activity in lupus erythematosus: correlation with the "lupus band test". J Invest Dermatol (1978) 0.80
Immunopathology of oral mucosal inflammatory diseases. Clin Exp Dermatol (1977) 0.79
Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen. J Lab Clin Med (1988) 0.79
An unusual manifestation of the carcinoid syndrome. Report of a case. Arch Dermatol (1968) 0.79
Immunofluorescence of epithelial skin tumors. II. Basement membrane. Cancer (1970) 0.79
Palmar keratoses and internal malignancy. A negative study. Arch Dermatol (1968) 0.79
Bullous pemphigoid following the topical use of fluorouracil. Arch Dermatol (1970) 0.79
Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes. J Clin Invest (1988) 0.79
Concurrent linear scleroderma and systemic lupus erythematosus: a report of two cases. J Invest Dermatol (1979) 0.79
Circulating immune complexes in systemic scleroderma and generalized morphea. Dermatologica (1980) 0.78
Bullous pemphigoid associated with systemic lupus erythematosus. Arch Dermatol (1969) 0.78
Brunsting-Perry cicatricial pemphigoid associated with bullous pemphigoid. J Am Acad Dermatol (1980) 0.78
A study of lupus erythematosus with particular reference to generalized discoid lupus. Br J Dermatol (1978) 0.77
The complement system in bullous pemphigoid: VII. Fixation of the regulatory protein beta 1H globulin by pemphigoid antibody. J Invest Dermatol (1980) 0.77
Immunohistochemical studies of the human cutaneous basement membrane-anchoring fibril complex. J Invest Dermatol (1977) 0.77
Pemphigus vegetans of Hallopeau: immunofluorescent studies. Arch Dermatol (1977) 0.77
Anti-Ro/SSA antibodies. Association with a particulate (large speckledlike thread) immunofluorescent nuclear staining pattern. Arch Dermatol (1985) 0.77
C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies. Arch Dermatol (1982) 0.77